Biotage AB (OTC: BITGY)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | -9.88 |
---|---|
% Price Change (last 13 weeks): | -9.14 |
% Price Change (last 26 weeks): | 14.15 |
% Price Change (last 52 weeks): | 21.60 |
% Price Change (year to date): | 13.74 |
Return on Equity (%): | 8.91 |
---|---|
Return on Assets (%): | 6.49 |
Return on Invested Capital (%): | 14.53 |
Gross Profit Margin (%): | 54.40 |
---|---|
Net Profit Margin (%): | 13.21 |
Operating Profit Margin (%): | 20.19 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products and services include sample preparation, horizon food and environmental products, organic synthesis, peptide chemistry, flash purification, work-up products, evaporation and concentration, and service and support. The company was founded by Pal Nyren, Carl Erik Mathias Uhlen, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Bjorn Ekstrom in 1969 and is headquartered in Uppsala, Sweden.
|
Biotage AB
Vimpelgatan 5 Uppsala UP 753 18 Phone: 46.18.56.59.00 Fax: 46.18.59.19.22 http://www.biotage.com |
Earnings (1year) ($): | 0.28 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 4.54 |
Cash Flow ($): | 0.47 |
Price/Earnings (x): | 53.22 |
---|---|
Price/Sales (x): | 5.60 |
Price/Book (x): | 2.93 |
Price/Cash Flow (x): | 36.70 |
Quick Ratio (x): | 1.43 |
---|---|
Current Ratio (x): | 2.05 |
LT Debt/Equity (x): | 10.20 |
Total Debt/Equity (x): | 17.15 |